MedPageToday: Sleep apnea specialists dumbfounded at critique of “gold standard” treatment.

The report — online at the AHRQ website and open for public comment through April 23 — concluded that the published evidence “mostly does not support that CPAP prescription affects long-term, clinically important outcomes,” and it highlighted research gaps and methodological weaknesses in the available studies, along with significant CPAP compliance issues, which have all contributed to the failure to show long-term benefits for the treatment.